Literature DB >> 28211044

Antibiotic use as a marker of acute infection and risk of first and recurrent venous thrombosis.

Jasmijn F Timp1, Suzanne C Cannegieter1,2,3, Vladimir Tichelaar4,5, Sigrid K Braekkan5, Frits R Rosendaal1,2, Saskia le Cessie1,6, Willem M Lijfering1,2.   

Abstract

A role for transient infections in the aetiology of venous thrombosis (VT) has been suggested. This study aimed to determine whether individuals who receive antibiotic treatment (as a proxy for infections) have an increased risk of first and recurrent VT and whether infections should be seen as a provoking risk factor for VT. We used the self-controlled case series method to study the risk of first VT during antibiotic prescriptions. The risk of recurrent VT during antibiotic use was estimated by of time-dependent Cox-regression. A total of 2547 patients with a first VT were included and followed for a median of 5·9 years for recurrence (1999-2010), in whom 114 first events occurred during antibiotic use. We found a five-fold increased risk of first VT during antibiotic treatment: [incidence-rate-ratio 5·0; 95% confidence interval (CI), 4·0-6·1]. Antibiotic use was associated with a 2·0-fold (95% CI, 1·1-4·0) increased risk of recurrent VT. Patients with an unprovoked first VT who used antibiotics shortly before this event, had a similar risk of recurrence as patients with a provoked first VT (adjusted hazard ratio 1·1; 95% CI, 0·7-1·7). Individuals who receive antibiotics have an increased risk of first and recurrent VT and infections should be considered a provoking risk factor for VT.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  antibiotics; epidemiology; infection; recurrence; venous thrombosis

Mesh:

Substances:

Year:  2017        PMID: 28211044     DOI: 10.1111/bjh.14551

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  4 in total

Review 1.  Epidemiology and prevention of venous thromboembolism.

Authors:  Pamela L Lutsey; Neil A Zakai
Journal:  Nat Rev Cardiol       Date:  2022-10-18       Impact factor: 49.421

2.  Risk of recurrent venous thromboembolism in patients with HIV infection: A nationwide cohort study.

Authors:  Casper Rokx; Jaime F Borjas Howard; Colette Smit; Ferdinand W Wit; Elise D Pieterman; Peter Reiss; Suzanne C Cannegieter; Willem M Lijfering; Karina Meijer; Wouter Bierman; Vladimir Tichelaar; Bart J A Rijnders
Journal:  PLoS Med       Date:  2020-05-14       Impact factor: 11.069

3.  Risk and Risk Factors Associated With Recurrent Venous Thromboembolism Following Surgery in Patients With History of Venous Thromboembolism.

Authors:  Banne Nemeth; Willem M Lijfering; Rob G H H Nelissen; Inger B Schipper; Frits R Rosendaal; Saskia le Cessie; Suzanne C Cannegieter
Journal:  JAMA Netw Open       Date:  2019-05-03

4.  Acute infection as a trigger for incident venous thromboembolism: Results from a population-based case-crossover study.

Authors:  Gro Grimnes; Trond Isaksen; Y I G Vladimir Tichelaar; Sigrid K Brækkan; John-Bjarne Hansen
Journal:  Res Pract Thromb Haemost       Date:  2017-12-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.